Gross margin moved 386 bp higher
Gross margin changed +386 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Gross margin changed +386 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Gross profit changed +44.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Inventory changed -46.9% from the comparable as-filed period.
Operating margin changed +5880 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Research & development changed -36.5% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Stock-based compensation changed -34.3% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Operating income changed +13.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Capital expenditure changed +5.1% from the comparable as-filed period. The change ranks at the 29th percentile of 7 prior comparable changes.
Cash & equivalents changed +10.7% from the comparable as-filed period.
Free-cash-flow proxy changed -9.1% from the comparable as-filed period. The change ranks at the 0th percentile of 7 prior comparable changes.
Operating cash flow changed -9.3% from the comparable as-filed period. The change ranks at the 0th percentile of 7 prior comparable changes.
Capex / revenue changed +51 basis points from the comparable as-filed period.
Net income changed -3.2% from the comparable as-filed period.
Revenue changed +0.5% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Selling, general & administrative changed +4.1% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.